Real-world Patterns of Adjuvant Chemotherapy Following Neoadjuvant Chemoradiation for Patients With Resected Rectal Adenocarcinoma
Conclusion:
Oxaliplatin-based adjuvant chemotherapy is not associated with improved survival outcomes compared with fluoropyrimidine-only chemotherapy in this real-world study.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Gastrointestinal Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Eloxatin | Gastroenterology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pathology | Rectal Cancers | Study